CD8A and breast cancer: Accordingly, 4T-1 tumors treated with taxifolin displayed a significant elevation of CD8+ T cells compared to 4T-1 tumors treated with DMSO, supporting the notion of taxifolin inhibiting BC in part via facilitating immune reactions.